نتایج جستجو برای: silibinin

تعداد نتایج: 656  

2010
Jin Kyung Rho Yun Jung Choi Byung-Suk Jeon Su Jin Choi Gi Jeong Cheon Sang-Keun Woo Hye-Ryoun Kim Cheol Hyeon Kim Chang-Min Choi Jae Cheol Lee

Although epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) produce an initially dramatic response in lung cancer patients harboring a mutation in the EGFR gene, development of acquired resistance is almost inevitable. A secondary mutation of threonine 790 (T790M) is associated with approximately half of the cases of acquired resistance. This study investigated whether the a...

Journal: :Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2011
Dennis Eurich Marcus Bahra Thomas Berg Sabine Boas-Knoop Michael Biermer Ruth Neuhaus Peter Neuhaus Ulf Neumann

OBJECTIVES Hepatitis C-virus-persistence after orthotopic liver transplant leads to reduced patient and graft survival compared to other indications. Current interferon-based antiviral therapy of hepatitis C-virus-infection posttransplant provides a sustained response rate of 30% to 40%. This study, performed in an hepatitis C-virus-reinfected liver transplant population, examines the antiviral...

Journal: :Indian Journal of Pharmaceutical Sciences 2023

The male reproductive system is vulnerable to oxidative stress, which linked several disorders. Silibinin, a natural polyphenolic flavonoid, possesses antioxidant, anti-inflammation and anticancer properties. Considering silibinin's wide range of biological metabolic roles (silibinin) plays, the current study was conducted evaluate biochemical, histological, immunohistochemical morphometric cha...

2004
Gu Mallikarjuna Sivanandhan Dhanalakshmi Rana P. Singh Chapla Agarwal Rajesh Agarwal

Here, we assessed the protective effect of silibinin on UVB-induced skin carcinogenesis in SKH-1 hairless mice. Topical application of silibinin before or immediately after UVB exposure or its dietary feeding resulted in a strong protection against photocarcinogenesis, in terms of tumor multiplicity (60–66%; P < 0.001), tumor volume per mouse (93–97%; P < 0.001) and tumor volume per tumor (80–9...

Journal: :Anticancer research 2008
Liguang Zhou Peishu Liu Bo Chen Yu Wang Xuping Wang Maurizio Chiriva Internati Mitchell S Wachtel Eldo E Frezza

BACKGROUND Drug resistance and tumor metastasis are the main causes of treatment failure and mortality in cancer patients. Silibinin, a naturally occurring flavanone, has been shown to be a potent sensitizer for apoptosis induced by a variety of anticancer drugs. In this study, whether silibinin could overcome chemoresistance and reduce the invasiveness of A2780/taxol cells was investigated. ...

2015
Wen-Jing Yan Ying-Chun Tan Ji-Cheng Xu Xian-Ping Tang Chong Zhang Peng-Bo Zhang Ze-Qiang Ren

Silibinin, a natural flavonoid antioxidant isolated from extracts of the milk thistle herb, has recently been identified as having anti-hepatotoxic and anticancer properties. In this paper, we investigated the effects of silibinin on behavior and neuroplasticity in mice subjected to chronic unpredictable mild stress (CUMS). After 5 consecutive weeks of CUMS, the mice were treated with silibinin...

2017
Federico Salomone Ignazio Barbagallo Justyna Godos Vincenzo Lembo Walter Currenti Diana Cinà Roberto Avola Nicolantonio D’Orazio Filomena Morisco Fabio Galvano Giovanni Li Volti

Nicotinamide adenine dinucleotide (NAD⁺) homeostasis is emerging as a key player in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and is tightly linked to the SIRT1/5'-AMP-activated protein kinase (AMPK) pathway. Silibinin, the main component of silymarin, has been proposed as a nutraceutical for the treatment of NAFLD. In this study, we aimed to identify whether silibinin may i...

2013
Sílvia Cufí Rosa Bonavia Alejandro Vazquez-Martin Cristina Oliveras-Ferraros Bruna Corominas-Faja Elisabet Cuyàs Begoña Martin-Castillo Enrique Barrajón-Catalán Joana Visa Antonio Segura-Carretero Jorge Joven Joaquim Bosch-Barrera Vicente Micol Javier A. Menendez

The flavolignan silibinin was studied for its ability to restore drug sensitivity to EGFR-mutant NSCLC xenografts with epithelial-to-mesenchymal transition (EMT)-driven resistance to erlotinib. As a single agent, silibinin significantly decreased the tumor volumes of erlotinib-refractory NSCLC xenografts by approximately 50%. Furthermore, the complete abrogation of tumor growth was observed wit...

2012
Young-Soo Lee Kyeung-Ae Jang Jeong-Dan Cha

Silibinin is a composition of the silymarin group as a hepatoprotective agent, and it exhibits various biological activities, including antibacterial activity. In this study, the antibacterial activities of silibinin were investigated in combination with two antimicrobial agents against oral bacteria. Silibinin was determined with MIC and MBC values ranging from 0.1 to 3.2 and 0.2 to 6.4  μg/mL...

Journal: :Carcinogenesis 2007
Yih-Shou Hsieh Shu-Chen Chu Shun-Fa Yang Pei-Ni Chen Yu-Chuan Liu Ko-Hsiu Lu

Silibinin is a natural flavonoid antioxidant with anti-hepatotoxic properties and pleiotropic anticancer capabilities. We tested the hypothesis that silibinin inhibits cellular invasiveness by down-regulating the focal adhesion kinase (FAK) and extracellular signal-regulated protein kinase (ERK)-dependent c-Jun/activator protein-1 (AP-1) induction, which leads to inhibition of urokinase-type pl...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید